XVIVO PERFUSION AB
XVIVO PERFUSION AB
Share · SE0004840718 · A1J5GZ (XSTO)
Overview
No Price
Closing Price XSTO 09.12.2025: 182,70 SEK
12.12.2025 07:01
Current Prices from XVIVO PERFUSION AB
ExchangeTickerCurrencyLast TradePriceDaily Change
XFRA: Frankfurt
Frankfurt
3XV.F
EUR
12.12.2025 07:01
16,66 EUR
0,57 EUR
+3,54 %
XDQU: Quotrix
Quotrix
XPABNA18.DUSD
EUR
12.12.2025 06:27
16,88 EUR
0,79 EUR
+4,91 %
XDUS: Düsseldorf
Düsseldorf
XPABNA18.DUSB
EUR
11.12.2025 18:31
16,64 EUR
0,66 EUR
+4,13 %
XSTO: NASDAQ STOCKHOLM AB
NASDAQ STOCKHOLM AB
XVIVO.ST
SEK
09.12.2025 08:45
182,70 SEK
-1,20 SEK
-0,65 %
OTC: UTC
UTC
XVIPF
USD
08.12.2025 21:00
19,64 USD
1,04 USD
+5,61 %
XLON: London
London
0RKL.L
SEK
08.12.2025 17:11
183,90 SEK
-1,80 SEK
-0,97 %
Share Float & Liquidity
Free Float 79,51 %
Shares Float 25,04 M
Shares Outstanding 31,5 M
Invested Funds

The following funds have invested in XVIVO PERFUSION AB:

Fund
iShares OMX Stockholm Capped UCITS ETF
Vol. in million
9.042,72
Percentage (%)
0,13 %
Company Profile for XVIVO PERFUSION AB Share
Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden.
Get up to date insights from finAgent about XVIVO PERFUSION AB

Company Data

Name XVIVO PERFUSION AB
Company Xvivo Perfusion AB (publ)
Website https://www.xvivoperfusion.com
Primary Exchange XSTO NASDAQ STOCKHOLM AB
WKN A1J5GZ
ISIN SE0004840718
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Christoffer Rosenblad
Market Capitalization 611 Mio
Country Sweden
Currency SEK
Employees 0,2 T
Address MAessans gata 10, 412 51 Gothenburg
IPO Date 2012-10-08

Ticker Symbols

Name Symbol
NASDAQ STOCKHOLM AB XVIVO.ST
Over The Counter XVIPF
Düsseldorf XPABNA18.DUSB
Frankfurt 3XV.F
London 0RKL.L
Quotrix XPABNA18.DUSD
More Shares
Investors who hold XVIVO PERFUSION AB also have the following shares in their portfolio:
IFA SYSTEMS AG
IFA SYSTEMS AG Share
Tian'an Pharmaceutical Co., Ltd.
Tian'an Pharmaceutical Co., Ltd. Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025